Triazolopyrazine derivatives useful as anti-cancer agents

Details for Australian Patent Application No. 2007251283 (hide)

Owner Pfizer Products Inc.

Inventors Johnson, Mary Catherine; Kania, Robert Steven; Chen, Hengmiao; TranDube, Michelle Bich; Nambu, Mitchell David; Hoffman, Jacqui Elizabeth; Shen, Hong; Pairish, Mason Alan; Jia, Lei; Le, Phuong Thi Quy; Cui, Jingrong Jean

Agent Allens Arthur Robinson

Pub. Number AU-A-2007251283

PCT Pub. Number WO2007/132308

Priority 60/799,966 11.05.06 US; 60/893,231 06.03.07 US

Filing date 30 April 2007

Wipo publication date 22 November 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/132308 Priority application(s): WO2007/132308

1 April 2010 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Chen, Hengmiao to Cheng, Hengmiao

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251289-Substituted piperidino phenyloxazolidinones

2007251282-Cycloalkylamino acid derivatives and pharmaceutical compositions thereof